April 18 (Reuters) - CSL Ltd (CSL) :
- CSL BEHRING RECEIVES FDA APPROVAL FOR HIZENTRA® (IMMUNE GLOBULIN SUBCUTANEOUS 20% LIQUID) 50ML PREFILLED SYRINGE
- CSL LTD - 50ML PREFILLED SYRINGE WILL BE AVAILABLE IN EARLY 2024
News: CSL Csl Behring Receives FDA Approval For Hizentra® (Immune Globulin Subcutaneous <Origin...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$263.70 |
Change
8.390(3.29%) |
Mkt cap ! $127.6B | |||
| Open | High | Low | Value | Volume |
| $258.12 | $264.16 | $257.91 | $157.7M | 602.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 36 | $263.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $263.72 | 89 | 12 |
View Market Depth
| Last trade - 13.52pm 22/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |